Diagnosis & Management of Thrombocytopenia: New Developments
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, November 4, 2010
8:00 am
Forchheimer 1st Floor Lecture Hall, Einstein
repeated at 12:15 pm
Cherhasky Auditorium, Montefiore
Speaker
James Bussell, MD
James B. Bussell, MD
Professor of Pediatrics, Weill Cornell Medical College
Professor of Pediatrics in Obstetrics and Gynecology, Weill Cornell Medical College
Professor of Pediatrics in Medicine, Weill Cornell Medical College
Attending Pediatrician, NewYork-Presbyterian Hospital
Dr. James Bussel is the director of the Platelet Disorders Program, focusing on understanding the pathophysiology of, and improved treatments for, thrombocytopenia, especially Immune Thrombocytopenic Purpura (ITP). Dr. Bussel lectures throughout the world on platelet disorders and advances in treatment and has chaired the American Society of Hematology (ASH) ITP symposium for seven consecutive years. A nationally and internationally renowned educator and recognized leader in clinical research trials in ITP, Dr. Bussel has performed seminal studies on the use of IVIG, Anti-D, Rituximab, and thrombopoietic agents in the management of refractory ITP. He developed the first successful management program of fetal alloimmune thrombocytopenia.
Dr. Bussel is the primary investigator of the Cornell-Columbia TMH Clinical Trial Network. Among his more than 200 publications are six first or second authored original articles in the New England Journal of Medicine.
Dr. Bussel attended Yale University undergraduate and Columbia University College for Physicians & Surgeons, and received his training at Children’s Hospital Medical Center, Cincinnati, emorial Sloan-Kettering Cancer Center, and the New York Hospital-Cornell Medical Center. Dr. Bussel holds board certifications in pediatrics and pediatric hematology-oncology and has an appointment in the Department of Medicine.
Accreditation
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.